ã¡ãã£ã¢èšäº
å»åž«14人ãã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ããºãææ°ããŒã¯ 261
twitterã³ã¡ã³ã 205ä»¶äž 1ïœ100件
ã€ã³ããã·ã¢ã§ã·ãããã¯ã¹ç€Ÿã®ã¯ã¯ãã³æ¥çš®åŸã«ã³ããææãæ»äº¡ããã±ãŒã¹ãå¢ããŠããšããå瀟ã®ã¯äžæŽ»åã¯ã¯ãã³ã§ããã¯ãããŸãå¹ããªãããã ããå¹ããªãã¯ã¯ãã³ã§ã¯æå³ãç¡ã
èŠå®åæ°ã®ã¯ã¯ãã³æ¥çš®åŸãæ°åã³ãããŠã€ã«ã¹ææçã§æ»äº¡ããŠããããšãå€æãååœã®å»åž«äŒã25æ¥çºè¡šããŸãã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè
ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ããã
äžåœè£œã¯å¹ããŸããã
ã€ã³ããã·ã¢ã¯äžåœã·ãããã¯è£œã¯ã¯ãã³ãäžå¿ã«æ®ããŠåœæ°ãžã®æ¥çš®ãé²ããŠããã
ãã¡ã€ã¶ãŒ
éãåºããããäžå»ãæ©ãéçºãã
å¡©é矩
éã¯åºããªããã©äžå»ãæ©ãéçºãã
ã·ãããã¯
éã¯åºããããäžå»ãæ©ãããŒã¿ããããã³ã°ããŠãã
éãåºããããäžå»ãæ©ãéçºãã
å¡©é矩
éã¯åºããªããã©äžå»ãæ©ãéçºãã
ã·ãããã¯
éã¯åºããããäžå»ãæ©ãããŒã¿ããããã³ã°ããŠãã
ã·ãããã¯è£œã¯ã¯ãã³ã¯ãã«ã¿æ ªã«å¯ŸããŠ50ïŒ
ã®æå¹æ§ããããäžçã®æææå¶ã«ã·ãããã¯è£œã¯è±èœãããã£ãŠããã人é¡ã¯ã³ããã«åãŠãªãã®ã
éçåé²æ¢ããªãããªïŒäžåœè£œã ãã©ã
ãã«ã¿æ ªã«ã¯äžåœã®äžæŽ»æ§åã¯ã¯ãã³ã¯å¹æã匱ããšããããšãã
é«éééãæ¡çšããæããå€ãã£ãŠãªã
æ¥çš®ããã®ããäžåœè£œã·ãããã¯ãšãããããäžéã§ãããïŒ
äžåœã§ãå¹æãçåèŠãããŠãããããïŒ
äœããã·ã³ã¬ããŒã«ããã¬ãŒã·ã¢çã®ASEANè«žåœã§ã¯ãæå€ãšã·ãããã¯äººæ°ã§ãã¡ã€ã¶ãŒ&ã¢ãã«ããç¡æãªã®ã«ææ...
äžåœã§ãå¹æãçåèŠãããŠãããããïŒ
äœããã·ã³ã¬ããŒã«ããã¬ãŒã·ã¢çã®ASEANè«žåœã§ã¯ãæå€ãšã·ãããã¯äººæ°ã§ãã¡ã€ã¶ãŒ&ã¢ãã«ããç¡æãªã®ã«ææ...
ã©ãã®åœã®ã¯ã¯ãã³äœ¿ã£ããããªïŒ
ã·ãããã¯ãšãã€ãªããã¯æ¥çš®ããŠãããã
âââ
âââ
ã€ãã æ»ã®ãã㯠ã¯ã¯ãã³æå¹æ§ç¡ãããããïŒ
ããããã©ããã®åœã§ãçç£ããããããã©ãåãªãççé£å¡©æ°Žãããªãã ãããªïŒ
ããããã©ããã®åœã§ãçç£ããããããã©ãåãªãççé£å¡©æ°Žãããªãã ãããªïŒ
äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯è£œã¯ã¯ãã³ã䜿çš
æ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠãã
æ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠãã
äžåœã®ã·ãããã¯ã¹ãâŠãã¿ã€ãã«ã«ã¡ãããšæžããŠãããŠã»ããã
æ®å¿µãªããšã«é Œã¿ãšããã·ãããã¯ã»ãã€ãªããã¯è£œã¯ã¯ãã³ã¯ãã®å¯ŠçžŸã§ãããé²ç«è²¬ä»»è
ã¯æ°£ãæ°£ã§ã¯ãªãã ããã
ããèšãã°ãªãªã³ããã¯åºå Žéžæãžã®æ¥çš®ã«ç¡åæäŸããããšãã宣èšãåããŠIOCäŒé·ãåãã ããšãããã¥ãŒã¹ããããŸãããã
ã€ã³ããã·ã¢ã¯äžåœã«äœåéšãããŠãæ²ãã²ããª(ÂŽã»Ïã»ïœ)
ã©ãã®ã¯ã¯ãã³âïž
ïŸïŸïœŒïŸïœžïŸïœ¶ïŸïŸïœ²ïœŽïŸ âïžð«
ãå»åž«14人
ã¯ã¯ãã³æ¥çš®ããã®ã«
ã³ããæ»äº¡ ã€ã³ããã·ã¢
äžãžã£ã¯ïŒCentral JavaïŒå·ã§ã¯ä»æ
æ¥çš®ãåããŠããå»çåŸäºè 300人以äž
æ°åãŠã€ã«ã¹ã«ææããŠããããšã確èªãã
ãã¡åæ°äººãå ¥é¢ããã
ïŸïŸïœŒïŸïœžïŸïœ¶ïŸïŸïœ²ïœŽïŸ âïžð«
ãå»åž«14人
ã¯ã¯ãã³æ¥çš®ããã®ã«
ã³ããæ»äº¡ ã€ã³ããã·ã¢
äžãžã£ã¯ïŒCentral JavaïŒå·ã§ã¯ä»æ
æ¥çš®ãåããŠããå»çåŸäºè 300人以äž
æ°åãŠã€ã«ã¹ã«ææããŠããããšã確èªãã
ãã¡åæ°äººãå ¥é¢ããã
ã€ã³ããã·ã¢ãã¯ã¯ãã³æ¥çš®å®äºã®å»åž«14åãæ»äº¡ãèšäºå
ã§ã¯æèšãããŠããªãããæ¥çš®ã¯ã¯ãã³ã¯äžæŽ»åã®ã·ãããã¯ã ããïŒ
ããã£ãŠADEã®å¯èœæ§ãããã®ããªïŒãã®å ãæªéã®æå±ããã®èŠè§£ãèããã®ããªïŒ
ããã£ãŠADEã®å¯èœæ§ãããã®ããªïŒãã®å ãæªéã®æå±ããã®èŠè§£ãèããã®ããªïŒ
ã·ãããã¯å
šç¶ãã¡ã ãªã
ã€ã³ããã·ã¢ã§ã®ã³ããçåšã奮ã£ãŠããã·ãããã¯ã¯ã¯ãã³ã®å¹æïŒ
äžæŽ»åã¯ã¯ãã³ã®å€ç°æ ªã«å¯Ÿããå¹æã¯ããããããšããã³ã¹ããæããã«ãªã£ãŠããâŠâŠ
ãšã¯ãã14/401ã ããããããªãã«å¹ããŠããã®ãããããªãã
ãšã¯ãã14/401ã ããããããªãã«å¹ããŠããã®ãããããªãã
ã·ãããã¯äºæ¡ïŒ
ããæžããªããšã人å£2å7000äžäººã®ã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšã
æ°èèšäºã«ãããšã·ãããã¯ã®ã¯ã¯ãã³ããã...
ãã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšã
ãªãã®åœã®ã¯ã¯ãã³ãæ¥çš®
ãŸããçŸåšã®ãããªã³ããçŠã®ç¶æ³ã§ã¯çå±ã°ããèšã£ãŠãŠãä»æ¹ãªããšæããŸããã©ãã
åŠè ããã ããä»æ¹ãªãã§ããããã©ã
äž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšãæ¥çš®ããŠãã€ã³ããã·ã¢ã§ã¯å€§å€ãªäºã«ãªã£ãŠãŸããããã
åŠè ããã ããä»æ¹ãªãã§ããããã©ã
äž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšãæ¥çš®ããŠãã€ã³ããã·ã¢ã§ã¯å€§å€ãªäºã«ãªã£ãŠãŸããããã
äžåœè£œã§ã¯ãã¡ã ãâšã€ã³ããã·ã¢ã¯ãäž»ã«äžåœã·ãããã¯è£œã®ã¯ã¯ãã³ã䜿çšãããããæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè
ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠãããïŒ
ããšã¯ãå§åçãªãã¡ã¯ãããRTCãæããã«æ»äº¡è
ãå¢ãããªã©å«ççãªé¢ãããäžæ¢ã«ããããšãããã®ã§ã
å»åž«14人ããªã»ãã·ã¥ã«ããããããæ»äº¡ ã€ã³ããã·ã¢
倧è£ïŒãå°ãèŽããŸãããããã¯ããã§ããïŒ
ã¯ã¯ãã³æ¥çš®è
ããææãæ¡ãããšããå¯èœæ§ã«ã€ããŠã¯ãåããææãããŠããã
æããã§ããïŒïŒ
å»åž«14人ãã¯ã¯ãã³æ¥çš®ã«ããããããã³ãå©ã§èèª ã€ã³ããã·ã¢
å»åž«14人ãã¯ã¯ãã³æ¥çš®ã«ããããããã³ãå©ã§èèª ã€ã³ããã·ã¢
æ çæ¥çš®ã§ãæ çæ»ãå€ãããã»ãšãã©ããã ãšæããã©ãååŽçããããã®ãšããŠå¯Ÿå¿ããŠããæ°ã³ãïŒã«çœ¹æ£ãããšæ çã§å
ç«ç³»ãç¡ååãããŠããããããããæ»ã¬ããšã«ãªãããæ çææªã
ã·ãããã¯è£œãšã¯ããããããŸã§éçåãé²ããªããšãªããšãäœãå¥ã®èŠå ãçããããªã
å€ç°æ ªãåå ãªããä»ç€Ÿè£œã¯ã¯ãã³ãå¹æãéä¿¡ãã¹ãã§ã¯ãªã
å€ç°æ ªãåå ãªããä»ç€Ÿè£œã¯ã¯ãã³ãå¹æãéä¿¡ãã¹ãã§ã¯ãªã
å»åž«14人ðæ çæ¥çš®ããã«ããããããã³ããã§æ»äº¡ã
â¡ðæ çæ¥çš®ããããã³ããã§æ»äº¡ãæ£è§£ã
è¡ç®¡å ã§è¡æ çãåŒãèµ·ããæãããã¹ãã€ã¯ã¿ã³ãã¯è³ªå ¥ãçæ¯æ çããæ¥çš®ããªããã°ãæ»ãªãã«æžãã ã®ã«ã
ãã€ã³ããã·ã¢ã
â¡ðæ çæ¥çš®ããããã³ããã§æ»äº¡ãæ£è§£ã
è¡ç®¡å ã§è¡æ çãåŒãèµ·ããæãããã¹ãã€ã¯ã¿ã³ãã¯è³ªå ¥ãçæ¯æ çããæ¥çš®ããªããã°ãæ»ãªãã«æžãã ã®ã«ã
ãã€ã³ããã·ã¢ã
ãã¯ãäžåœè£œ
ããããð¥
AFP
ãã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯è£œã®ã¯ã¯ãã³ã䜿çšããŠã1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»ã ãããããæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠãããã
ãã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯è£œã®ã¯ã¯ãã³ã䜿çšããŠã1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»ã ãããããæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠãããã
ã·ãããã¯ãã
ã¯ã¯ãã³æã£ãŠãã³ããè¶çªã¯çµãããªããã
å»åž«14人ãã¯ã¯ãã³æ¥çš®(ã·ãããã¯)ã«ããããããã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ãååœã§ã¯ã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè
ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ãããã
ãã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè
ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ãããâããããããå€ç°æ ªã«ææããŠADEãèµ·ããŠããã®ã§ã¯ãªããããã
ã³ããã¯ã¯ãã³ä»äºããŠïŒ
æ¥çš®ã«ããããããã£ãŠããæ¥çš®ããããäœèšã«ãããð
ã€ã³ããã·ã¢ïŒ
éçåããªãçºã®ææ²ã ã£ãã®ã§ã¯âïž
æ¥çš®åŸã«éçåããŸããŠãæ»äº¡ãšãªããšæçæ¥çš®ã®æ矩ãã®ãã®ãçããããããªãã
ååœã§ã¯ã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ããã
æ¥çš®åŸã«éçåããŸããŠãæ»äº¡ãšãªããšæçæ¥çš®ã®æ矩ãã®ãã®ãçããããããªãã
ååœã§ã¯ã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ããã
äžæŽ»åã¯ã¯ãã³ããããã©ããã®ã¿ã€ãã®ã¯ã¯ãã³ããå¹æãèãã£ãŠäºãªã®ããã(*ÂŽ-`)
ã·ãããã¯è£œã¯ã¯ãã³ã
ãååœã§ã¯ã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè
ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ãããã
ãã®ã°ã£ã
äž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšããŠ1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»æ¥çš®ãåããŠããã«ããããããéçåããå»çåŸäºè
ãå¢ããŠãã
ã³ããçŠããããâ¿äººé¡â
æŽè³æŠäºäžã«ãããŠã®âã¯ã¯ãã³ã¯â
æŽè³å
µåšïŒ
âäžåŠçã«â æ¥çš®ãããšãïŒð¹
âå»åž«14人â ã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ïŒãšãð»
ð¥ºç°ãªãâNewsãâ æ å ±æŠã®â措氎ã§â¿äººã ã®æèãâ åæ¢ãããã®ãç®çãïŒ
âäžåŠçã«â æ¥çš®ãããšãïŒð¹
âå»åž«14人â ã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ïŒãšãð»
ð¥ºç°ãªãâNewsãâ æ å ±æŠã®â措氎ã§â¿äººã ã®æèãâ åæ¢ãããã®ãç®çãïŒ
äžåœè£œã·ãããã¯ã¯ã¯ãã³æ¥çš®ããŠãŠãæ»äº¡âŠ
ã³ãã補é åœã®äžåœã®ã¯ã¯ãã³ãå¹ããªããªããªããŠ
æ³å®å€å€ç°ãªã®ãæ³å®ããŠãã®ã
ãããšããåœå åãã®ã¯ã¯ãã³ãš
ã¯ã¯ãã³å€äº€çšã®ã¯ã¯ãã³ã¯éãã®ãªïŒ
ã³ãã補é åœã®äžåœã®ã¯ã¯ãã³ãå¹ããªããªããªããŠ
æ³å®å€å€ç°ãªã®ãæ³å®ããŠãã®ã
ãããšããåœå åãã®ã¯ã¯ãã³ãš
ã¯ã¯ãã³å€äº€çšã®ã¯ã¯ãã³ã¯éãã®ãªïŒ
ã¯ã¯ãã³ã®ããªããããŽããªããŠæ¥çš®ããŠãæå³ãªãã£ãŠããšãããã
ãããéžæè¢ã«å ¥ãããšãéšãã§ã銬鹿ãªå»è ãããããã
ãããéžæè¢ã«å ¥ãããšãéšãã§ã銬鹿ãªå»è ãããããã
ã·ãããã¯
AFPBBïŒ6/26
å»åž«äŒïŒ25æ¥
âã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè ãéçåããã±ãŒã¹ãçžæ¬¡ã
âäžãžã£ã¯å·ïŒä»æãæ¥çš®ãåããŠããå»çåŸäºè 300人以äžææ確èªïŒãã¡åæ°äººãå ¥é¢
å»åž«äŒïŒ25æ¥
âã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè ãéçåããã±ãŒã¹ãçžæ¬¡ã
âäžãžã£ã¯å·ïŒä»æãæ¥çš®ãåããŠããå»çåŸäºè 300人以äžææ確èªïŒãã¡åæ°äººãå ¥é¢
"人å£2å7000äžäººã®ã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšããŠã1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»ã ã"
ãŸãã«ãæ»ã®ããã¯ã
äžåœè£œã®ã·ãããã¯ãã¯ã¯ãã³æã£ãŠãä»æµè¡ãã®ã³ããã«ã¯ç¡å¹âŒïžð€£ð
äžåœã®äœã£ããŠã€ã«ã¹ã«ãããæŽã«å¹ããããªãã¯ã¯ãã³è¿æã£ãŠæ»ãã å»çåŸäºè ããªã¬ãªã¬è©æ¬ºã®è¢«å®³è 以äžã®åãããå»åž«14人ãã¯ã¯ãã³æ¥çš®ã§ãã³ããã§æ»äº¡ ã€ã³ããã·ã¢
äžåœè£œã®ã·ãããã¯ãã¯ã¯ãã³æã£ãŠãä»æµè¡ãã®ã³ããã«ã¯ç¡å¹âŒïžð€£ð
äžåœã®äœã£ããŠã€ã«ã¹ã«ãããæŽã«å¹ããããªãã¯ã¯ãã³è¿æã£ãŠæ»ãã å»çåŸäºè ããªã¬ãªã¬è©æ¬ºã®è¢«å®³è 以äžã®åãããå»åž«14人ãã¯ã¯ãã³æ¥çš®ã§ãã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ã·ãããã¯ïŒ
ãã®èšäº ã¯åçš®æ°åã³ããã¯ã¯ãã³ã®æå¹æ§ã®æ¯èŒè¡šãšããããŠãèªã¿ããã ããããã®ã§ãã
ã ã ã
>
>
ãŸãäžåœã·ãããã¯è£œã®ã¯ã¯ãã³ã§ã®æ»è
ã·ãããã¯å¹æèãã£ãŠå å¡ãèšããã£ãŠãããããæäœéå»çåŸäºè ã¯å¥ã®ãã®ãæ¥çš®ãçŽããæ¹ãããã®ã§ã¯
ã·ãããã¯å¹æèãã£ãŠå å¡ãèšããã£ãŠãããããæäœéå»çåŸäºè ã¯å¥ã®ãã®ãæ¥çš®ãçŽããæ¹ãããã®ã§ã¯
ãã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çšããŠã
ãã£ã±ãã·ãããã¯ã®ã¯å¹æã«çå笊ãä»ãã®ã§ã¯âŠ
ãã£ã±ãã·ãããã¯ã®ã¯å¹æã«çå笊ãä»ãã®ã§ã¯âŠ
æ¥æ¬ã®ãã¬ãã§ã¯å ±éããªãã§ããããð
ã€ã³ããã·ã¢ã§ã¯ãææããŠæ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠããããšã®ããšã§(æ¥æ¬ã§ã®å»åž«æ»äº¡ã¯å
¬åŒã«ã¯3人ïŒ)ãæ¥çš®åŸã«éçåããå»çåŸäºè
ãå¢ããŠããã®ãåé¡ã«ãªã£ãŠãããããåææã®å»çåŸäºè
ã®æ¥çš®çãšéæ¥çš®è
ã®æ»äº¡ã¯ã©ããªãã§ãããã
äžè¯æ§ãæ°Žãªã®ããäžè¯æ§ã®ããã¢ã³ãã
ãããã«ããã¯ã¯ãã³ã¯ãã¡ã ã (-_-;)
ãããã«ããã¯ã¯ãã³ã¯ãã¡ã ã (-_-;)
èšäºã«ãããšãã€ã³ããã·ã¢ã¯äž»ã«äžåœè£œè¬å€§æã·ãããã¯ã®ã¯ã¯ãã³ã䜿çšããŠããŠãæ¥çš®ããŠãéçåããå»çåŸäºè
ãå¢ããŠããããšã§ãæå¹æ§ã«ç念ãçããŠããããã§ãã
ã€ã³ããã·ã¢ã§èŠå®åæ°ã®ã¯ã¯ãã³æ¥çš®ã®å»çåŸäºè
ãæ»äº¡ãã
ã€ã³ããã·ã¢ã¯äžåœè£œã®ã¯ã¯ãã³ãã·ãããã¯è£œãæ¥çš®ããŠãã
ã€ã³ããã·ã¢ã¯äžåœè£œã®ã¯ã¯ãã³ãã·ãããã¯è£œãæ¥çš®ããŠãã
æ¥æ¬ããã¡æ©ãå
šåœæ°åã®mRNAã¯ã¯ãã³ã確ä¿ã§ããã®ã¯å¥åã ã£ããšããã
å»åž«14人ãã·ãããã¯ã®ã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ã·ãããã¯ã®ã¯ã¯ãã³ã䜿çšããŠã1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»
ããããæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念
ã·ãããã¯ã®ã¯ã¯ãã³ã䜿çšããŠã1å8000äžäººä»¥äžã®æ¥çš®ãæ¥å¹ŽåããŸã§ã«çµããèšç»
ããããæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念
æ»ã®ããã¯
ã ããã¡ãããã®ããããã¯ã¯ãã³ã¯ãããšããšããã»ã©âŠã
â
â
äžæŽ»åã¯ã¯ãã³ã ãããªã®ã
第äžç« ã®å§ãŸãã
第äžç« ã®å§ãŸãã
çŸç¶
æ¥æ¬åœå ã¯ç·æ¥äºæ ãè延é²æ¢
äžçãææåæ¡å€§äž
æ±äº¬äºèŒªãžåå ããããšããåœã¯
èªåœã®å€ç°çš®ãæ¥æ¬ã«å ¥ããªã
æ¥æ¬ã®å€ç°çš®ãèªåœã«æã¡åž°ããªã
æ¥æ¬ã¯ã¯ã¯ãã³æªæ¥çš®è ã
äžå人以äžãã
å»åž«14人ã¯ã¯ãã³æ¥çš®ã
ã³ããã§æ»äº¡ ã€ã³ããã·ã¢
æ¥æ¬åœå ã¯ç·æ¥äºæ ãè延é²æ¢
äžçãææåæ¡å€§äž
æ±äº¬äºèŒªãžåå ããããšããåœã¯
èªåœã®å€ç°çš®ãæ¥æ¬ã«å ¥ããªã
æ¥æ¬ã®å€ç°çš®ãèªåœã«æã¡åž°ããªã
æ¥æ¬ã¯ã¯ã¯ãã³æªæ¥çš®è ã
äžå人以äžãã
å»åž«14人ã¯ã¯ãã³æ¥çš®ã
ã³ããã§æ»äº¡ ã€ã³ããã·ã¢
"ã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯ïŒSinovac BiotechïŒè£œã®ã¯ã¯ãã³ã䜿çš"
ã»èŠå®åæ°ã®ã¯ã¯ãã³æ¥çš®ãåããŠããã®ã«ãæ°åã³ãããŠã€ã«ã¹ææçã§æ»äº¡ããäºäŸãå€çº
ã»ã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã®ã¯ã¯ãã³ã䜿ã£ãŠãã
â
äžåœè£œãžã®ç念ããæŽã«å¢å
ã»ã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã®ã¯ã¯ãã³ã䜿ã£ãŠãã
â
äžåœè£œãžã®ç念ããæŽã«å¢å
åã誀解ãäžããèŠåºãð
1.ã¯ã¯ãã³ãšã®é¢ä¿èª¿æ»äž
å šéšèªãŸãªããšã¯ã¯ãã³ãå šãŠæªããšããå°è±¡æäœ
1.ã¯ã¯ãã³ãšã®é¢ä¿èª¿æ»äž
å šéšèªãŸãªããšã¯ã¯ãã³ãå šãŠæªããšããå°è±¡æäœ
ããããäºäŸãã¯ã¯ãã³æ¥çš®æšé²æŽŸã¯ã©ã説æããã®ã ãããïŒâ¶ïž
ååœã§æ°åã³ããã«ããæ»äº¡ããå»çåŸäºè
ã¯çŽ¯èšã§å人è¿ãã«äžãã
ã€ã³ããã·ã¢å»åž«äŒã¯ãææã§æ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãããšæããã«ãã(14人以å€ã¯çŸåšç¢ºèªäž)ã
ã€ã³ããã·ã¢å»åž«äŒã¯ãææã§æ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãããšæããã«ãã(14人以å€ã¯çŸåšç¢ºèªäž)ã
ã¯ã¯ãã³æ¥çš®ãããããšèšã£ãŠãçŽãã«é£²ã¿æ©ãããããã¹ã¯å€ãããâŠãšããã¡ã ãšããäº!?ãããâŠå»åž«14人ã亡ããªãããã®ã¯å€ããã¯ã¯ãã³ãè²ã
é£ãã!?
ãæãã¿ç³ãäžããŸãã
ãæãã¿ç³ãäžããŸãã
ã¯ã¯ãã³ããã¹ã¯äžŠã¿ã®å¶åŸ¡å¹æãããªã蚌æ ã§ãããã
æ°åãŠã€ã«ã¹ã«ææããŠæ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãããšæããã«ããã
â
ã·ãããã¯96%ãæ»äº¡çæžãããŠãããã
â
ã·ãããã¯96%ãæ»äº¡çæžãããŠãããã
äžè¯ã¯ã¯ãã³ã®æ¥çš®ããããã
å°ããå»è
æ§ã®åœã亡ããªã£ãŠããŸã£ããïŒ
å»çåŸäºè æ§éã®ãé°ã§ç§ãã¡çããŠè¡ãããŠãã®ã«ã
ã¯ã¯ãã³çµ¶å¯ŸãããªããïŒ
å»çåŸäºè æ§éã®ãé°ã§ç§ãã¡çããŠè¡ãããŠãã®ã«ã
ã¯ã¯ãã³çµ¶å¯ŸãããªããïŒ
åŒçšïŒã¯ã¯ãã³æ¥çš®ãåããå»çåŸäºè
ãéçåããã±ãŒã¹ãçžæ¬¡ãã§ãã
æ°åãŠã€ã«ã¹ã«ææããŠæ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãã
æ°åãŠã€ã«ã¹ã«ææããŠæ»äº¡ããå»åž«401人ã®ãã¡14人ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãã
ã¯ã¯ãã³ å¹ãããããªãã®ïŒ
ã©ãããšïŒ
å¹ããããªãã®ã« å€ãªç©è³ªã 身äœã«æ³šå ¥ããŠãã®ïŒ
ã©ãããšïŒ
å¹ããããªãã®ã« å€ãªç©è³ªã 身äœã«æ³šå ¥ããŠãã®ïŒ
ãããŸãâ
äžè¯ã¯ã¯ãã³çã(;ÂŽÐ`)
å»åž«14人ãäžåœã®ã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ã·ãããã¯ã®ã¯ã話ã«ãªããªãããã ã
ããã®ã§ãè¯ãããæ¥æ¬ã«ãæ©æã«å°å ¥ããã£ãŠèšã£ãŠã人ãããªã
ããã®ã§ãè¯ãããæ¥æ¬ã«ãæ©æã«å°å ¥ããã£ãŠèšã£ãŠã人ãããªã
å»åž«14人ãäžåœè£œã¯ã¯ãã³æ¥çš®ã«ããããããã³ããã§æ»äº¡ ã€ã³ããã·ã¢
ã¿ã€ãã«ã«äžåœè£œã£ãŠå
¥ãå¿ããïŒ
æžãŸããŠãŠãæ»äº¡ãããã°éçã«ãªããšããããšã ãå¥ã«ã€ã³ããã·ã¢ãç¹å¥ãããªããæãåœð¯ðµã§ãèšããããšã QT
ãã€ã³ããã·ã¢ã¯ãäž»ã«äžåœè£œè¬å€§æã·ãããã¯ã»ãã€ãªããã¯[âŠ]補ã®ã¯ã¯ãã³ã䜿çšã
ãæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠããã
ãæ¥çš®ãåããŠããã«ãããããããéçåããå»çåŸäºè ãå¢ããŠããããšã§ããã®æå¹æ§ã«ç念ãçããŠããã
ããªããšã¯ã¯ãã³ã¯ãäžåœè£œã·ãããã¯ã ã£ãïŒ
æ¥æ¬è£œã®ã¯ã¯ãã³ãåŸ
ã£ãŠãããæ¥å¹Žã®ïŒæãããšãã
å㞠次ãž